Navigation Links
BOTOX® Cosmetic Botulinum Toxin Type A

ProductsBOTOX® Cosmetic Botulinum Toxin Type A
Company Allergan, Inc.
Item BOTOX® Cosmetic Botulinum Toxin Type A
Features 
Description BOTOX® Cosmetic is a simple, nonsurgical, physician-administered treatment that can temporarily smooth moderate to severe frown lines between the brows in people from 18 to 65 years of age. It is the only treatment of its type approved by the Food and Drug Administration (FDA).

BOTOX® Cosmetic is a purified protein produced by the Clostridium botulinum bacterium, which reduces the activity of the muscles that cause those frown lines between the brows to form over time

Info Allergan, Inc.
Customer Service: (714) 246-4500
Web site: http://www.allergan.com

Related medicine products :

1. Erbium Laser with Sapphire Erbium Handpiece for Dermatological and Cosmetic Surgery
2. Equinox Cosmetic Enhancement Contact Lens
3. Myobloc®(Botulinum Toxin Type B) Injectable Solution
4. Dysport® Clostridium Botulinum Type A
5. Clostridium Difficile Toxin A RAPYDTEST®
6. ImmunoCard STAT! Toxin A
7. Premier C. difficile Toxin A
8. BD ColorPAC Toxin A C. difficile Rapid Toxin A Test
9. VIDAS Clostridium difficile (Toxin A) assay
10. Bartels® C. Difficile Toxin A Antigen EIA with Controls
11. Xpect Clostridium difficile Toxin A/B Test Kit
... bags are part of the Freedom ... of leg bags, kits, and accessories ... of our customers. These leg bags ... constructed of 100% latex-free soft, textured ...
... leg bags are part of the ... line of leg bags, kits, and ... needs of our customers. These leg ... and constructed of 100% latex-free soft, ...
The latex-free, PVC-free Antibacterial Hydro Personal catheter combines two remarkable innovations into one exclusive catheter that delivers an antibacterial agent while providing the virtually frict...
The Antibacterial Personal Catheter® features a unique silicone composition that provides an antibacterial coated soft outer layer of silicone combined with a firm inner layer....
Medicine Products:
(Date:8/16/2017)... ... August 16, 2017 , ... Melbourne’s reign as the world’s most liveable ... Unit’s (EIU) annual Liveability Index. , The Index surveys 140 of the world’s cities ... 2006, Melbourne has consistently come in the top three of the index. So what ...
(Date:8/16/2017)... ... August 16, 2017 , ... Connexion Point, a technology-enabled healthcare services company ... fourth consecutive year. With 197% revenue growth over the past three years, ... growing companies. , Previous honors include ranking 86th on the Inc. 500 ...
(Date:8/16/2017)... Rochester, Michigan (PRWEB) , ... August 16, 2017 ... ... treatment options to patients suffering from chronic pelvic pain. In addition to ... various pelvic pain disorders including endometriosis, menorrhagia (abnormal heavy bleeding during menstruation), uterine ...
(Date:8/16/2017)... (PRWEB) , ... August 16, 2017 , ... ... an annual all-encompassing awards program which recognizes organizations that demonstrate the core values ... of comprehensive award categories. , “As a global company, we are expanding our ...
(Date:8/16/2017)... ... ... “Mom, God's Got This: Jamie's Story” is the creation of published author, Karen F. Norton, ... insatiable appetite for God’s Word. , “I froze between the half walls, shelves on my ... oatmeal. I have one to this day on proud display in my dining room hutch; ...
Breaking Medicine News(10 mins):
(Date:8/1/2017)... CerSci Therapeutics , a non-opioid drug development firm based ... notice from the National Institute on Drug Abuse (NIDA) ... has been awarded a Direct-to-Phase II Small Business Innovation ... an additional $1,000,000 to follow in 2018. These funds ... lead non-opioid drug candidate CT-044 to the Food and ...
(Date:7/28/2017)... 2017 EnvoyHealth, a Diplomat company, has partnered with ... CleverCap LITE, a technology designed to improve patient medication ... health technology solutions and services that help track and ... CleverCap LITE offers medication monitoring and control for ... Records date and time ...
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals Company, ... our clinical trial evaluating Altemia TM , an oral ... and Sickle Cell Disease (SCD). The SCOT Trial, is ... efficacy and safety of Altemia TM in pediatric ... under US IND 125274. ...
Breaking Medicine Technology: